Lomondther
1 known investors
Find your way into Lomondther
1,015 people in our graph share verified history with the Lomondther team — schools, employers, funds. One of them is your warm intro.
Dominic Jacquessonunlockedknows Iain Dukes · together at University of Oxford (overlapped)
knows the team · via University of Oxford
×2knows the team · via GlaxoSmithKline
×3knows the team · via University of Leeds
×4knows the team · via University of Bath
knows the team · via Amgen
Lomond Therapeutics is a small molecule oncology drug discovery company developing differentiated therapies that target biological pathways with resistant mutations and escape mechanisms in hematologic malignancies. It focuses on pan-variant therapies aimed at overcoming resistance in current cancer treatments.
Founders & leadership
ID
NS
Nikolay SavchukCOO
AB
Amy BurdCSO
BL
Brian LedwithChief Development Officer
FP
Fraser PickersgillHead CMC
JB
John ByrdInterim Chief Medical Officer
Investors · 1
Frequently asked questions
- What does Lomondther do?
- Lomond Therapeutics is a small molecule oncology drug discovery company developing differentiated therapies that target biological pathways with resistant mutations and escape mechanisms in hematologic malignancies. It focuses on pan-variant therapies aimed at overcoming resistance in current cancer treatments.
- Who founded Lomondther?
- Lomondther was founded by Iain Dukes.
- Who are Lomondther's investors?
- Lomondther's investors include OrbiMed.